Covered recipient · General Payments record
BRIAN ALAN BAXTER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,357.52
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $293.05 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $138.93 | 7 |
| Lilly USA, LLC | $34.80 | 2 |
| Otsuka America Pharmaceutical, Inc. | $31.76 | 2 |
| Acerta Pharma LLC | $30.67 | 2 |
| DEXCOM, INC. | $25.30 | 1 |
| GlaxoSmithKline, LLC. | $17.17 | 1 |
| Novo Nordisk AS | $14.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.53 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293389 | CMS |
| ABBVIE INC. | $28.30 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293391 | CMS |
| ABBVIE INC. | $16.27 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293393 | CMS |
| ABBVIE INC. | $21.69 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293395 | CMS |
| ABBVIE INC. | $18.98 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293397 | CMS |
| ABBVIE INC. | $22.42 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293399 | CMS |
| ABBVIE INC. | $10.74 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103293401 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.11 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105513609 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.56 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104648617 | CMS |
| Dexcom, Inc. | $25.30 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153287808 | CMS |
| GlaxoSmithKline, LLC. | $17.17 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115786651 | CMS |
| Lilly USA, LLC | $17.85 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136071627 | CMS |
| Lilly USA, LLC | $16.95 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136022234 | CMS |
| Novo Nordisk Inc | $14.42 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096630456 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.20 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118859707 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.56 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118859709 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.